EVALUATION OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER: SYSTEMATIC REVIEW AND TRIAL LEVEL META-ANALYSIS

被引：0
|
作者：
Adunlin, G. [1 ]
Dranitsaris, G. [2 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
[2] Augmentium Pharma Consulting Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1536
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN203
引用
收藏
页码：A170 / A170
页数：1
相关论文
共 50 条
  • [31] Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis
    George Adunlin
    John W. W. Cyrus
    George Dranitsaris
    Breast Cancer Research and Treatment, 2015, 154 : 591 - 608
  • [32] Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis
    Paoletti, Xavier
    Lewsley, Liz-Anne
    Daniele, Gennaro
    Cook, Adrian
    Yanaihara, Nozomu
    Tinker, Anna
    Kristensen, Gunnar
    Ottevanger, Petronella B.
    Aravantinos, Gerasimos
    Miller, Austin
    Boere, Ingrid A.
    Fruscio, Robert
    Reyners, Anna K. L.
    Pujade-Lauraine, Eric
    Harkin, Andrea
    Pignata, Sandro
    Kagimura, Tatsuo
    Welch, Stephen
    Paul, James
    Karamouza, Eleni
    Glasspool, Rosalind M.
    JAMA NETWORK OPEN, 2020, 3 (01)
  • [33] Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis
    Adunlin, George
    Cyrus, John W. W.
    Dranitsaris, George
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 154 (03) : 591 - 608
  • [34] Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
    Lisa Belin
    Aidan Tan
    Yann De Rycke
    Agnès Dechartres
    British Journal of Cancer, 2020, 122 : 1707 - 1714
  • [35] Radiographic progression-free survival as a surrogate endpoint of overall survival in men with metastatic castrate-resistant prostate cancer.
    Halabi, Susan
    Roy, Akash
    Yang, Qian
    Xie, Wanling
    Kelly, William Kevin
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Progression-free survival and overall survival of pembrolizumab for patients with esophageal cancer: a meta-analysis
    Kurniawan, A.
    Wijovi, F.
    Angel, P.
    Priantono, D.
    Sari, C.
    Amelia, D. Astri Rivera
    Djatnika, D.
    Nasution, M. Arman
    Purlikasari, N. Prasasti
    Ariyanti, F.
    Wisman, B. Agustia
    Kurniawan, R.
    Sinurat, J.
    Ardian, A.
    Sugianto, G. Chandra Kirana
    Siregar, N. Novianti
    Dewi, N. Merlynda P.
    ANNALS OF ONCOLOGY, 2024, 35 : S1365 - S1365
  • [37] Progression-free survival and overall survival of pembrolizumab for patients with esophageal cancer: a meta-analysis
    Santoso, K. Aurelia
    Kosayuz, S.
    Atmaja, W. Surya
    Amalia, A. Irviani Ukhti
    Subroto, D. Ravinder Theodeus
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1365 - S1365
  • [38] Evaluation of progression-free survival as a surrogate end point in primary CNS lymphoma: a systematic review and meta-analysis
    Zhan, Jing
    Yang, Shijie
    Zhang, Wei
    Zhou, Daobin
    Zhao, Danqing
    Zhang, Yan
    Wang, Wei
    Wei, Chong
    FUTURE ONCOLOGY, 2023, 19 (31) : 2123 - 2133
  • [39] Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors
    Chowdhury, Simon
    Mainwaring, Paul
    Zhang, Liangcai
    Mundle, Suneel
    Pollozi, Eneida
    Gray, Alexander
    Wildgust, Mark
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [40] Progression-free survival as a surrogate for overall survival in advanced cancer.
    Gillies, Eric
    Holdai, Veera
    Cowall, David Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345